Glycemic Index, Glycemic Control and Beyond

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3620-3630

Bentham Science Publishers

Access to resources Recommend Favorite

Preventing macrovascular complications of diabetes: where do we stand with glycemic control?

By Athyros Vasilios G   Tziomalos Konstantinos   Karagiannis Asterios   Mikhailidis Dimitri P  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1777-1779

Informa Healthcare

Access to resources Recommend Favorite

Identifying and Attaining LDL-C Goals: Mission Accomplished? Next Target: New Therapeutic Options to Raise HDL-C Levels

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-01 ,pp. : 483-488

Bentham Science Publishers

Access to resources Recommend Favorite

The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

By Fujii Yuki   Abe Masanori   Higuchi Terumi   Mizuno Mari   Suzuki Hiroko   Matsumoto Shiro   Ito Midori   Maruyama Noriaki   Okada Kazuyoshi   Soma Masayoshi  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 3, 2013-02 ,pp. : 259-267

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis

By Abe Masanori   Okada Kazuyoshi   Maruyama Takashi   Maruyama Noriaki   Matsumoto Koichi  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 169-176

Informa Healthcare

Access to resources Recommend Favorite